Fabinet Logo
Journal Article

Mid-ATR-FTIR spectroscopic profiling of HIV/AIDS sera for novel systems diagnostics in global health

Sitole, L.,Steffens, F.,Krüger, T.P.J.,Meyer, D.
Year2014
JournalOMICS A Journal of Integrative Biology
Volume18

Abstract

Abstract Global health, whether in developed or developing countries, is in need of robust systems diagnostics for major diseases, such as HIV/AIDS, impacting the world populations. Fourier transform Infrared (FTIR) spectroscopy of serum is a quick and reagent-free methodology with which to analyze metabolic alterations such as those caused by disease or treatment. In this study, Attenuated Total Reflectance Fourier-Transform (ATR-FTIR) Spectroscopy was investigated as a means of distinguishing HIV-infected treatment-experienced (HIV pos ART pos , n =39) and HIV-infected-treatment-naïve (HIV pos ART neg , n =16) subjects from uninfected control subjects ( n =30). Multivariate pattern recognition techniques, including partial least squares discriminant analysis (PLS-DA) and orthogonal partial least squares discriminant analysis (OPLS-DA), successfully distinguished sample classes, while univariate approaches identified significant differences ( p <0.05) after Benjamini-Hochberg corrections. OPLS-DA discriminated between all groups with sensitivity, specificity, and accuracy of >90%. Compared to uninfected controls, HIV pos ART pos and HIV pos ART neg subjects displayed significant differences in spectral regions linked to lipids/fatty acids (3010 cm −1 ), carbohydrates (1299 cm −1 ; 1498 cm −1 ), glucose (1035 cm −1 ), and proteins (1600 cm −1 ; 1652 cm −1 ). These are all molecules shown by conventional biochemical analysis to be affected by HIV/ART interference. The biofluid metabolomics approach applied here successfully differentiated global metabolic profiles of HIV-infected patients and uninfected controls and detected potential biomarkers for development into indicators of host response to treatment and/or disease progression. Our findings therefore contribute to ongoing efforts for capacity-building in global health for robust omics science and systems diagnostics towards major diseases impacting population health.